MacroGenics, Inc. (MGNX)
MacroGenics Market Cap : 130.31M for Nov. 17, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 16, 2026 | 138.61M |
| November 13, 2026 | 140.53M |
| November 12, 2026 | 146.28M |
| November 11, 2026 | 148.19M |
| November 10, 2026 | 154.58M |
| November 09, 2026 | 148.93M |
| November 06, 2026 | 148.29M |
| November 05, 2026 | 141.29M |
| November 04, 2026 | 147.02M |
| November 03, 2026 | 148.29M |
| November 02, 2026 | 148.29M |
| October 30, 2026 | 152.75M |
| October 29, 2026 | 151.48M |
| October 28, 2026 | 157.20M |
| October 27, 2026 | 155.30M |
| October 26, 2026 | 139.38M |
| October 23, 2026 | 143.20M |
| October 22, 2026 | 231.03M |
| October 21, 2026 | 228.49M |
| October 20, 2026 | 222.12M |
| October 19, 2026 | 211.94M |
| October 16, 2026 | 206.85M |
| October 15, 2026 | 214.49M |
| October 14, 2026 | 210.67M |
| October 13, 2026 | 217.67M |
| Date | Value |
|---|---|
| October 12, 2026 | 236.76M |
| October 09, 2026 | 238.03M |
| October 08, 2026 | 225.94M |
| October 07, 2026 | 225.94M |
| October 06, 2026 | 231.67M |
| October 05, 2026 | 239.94M |
| October 02, 2026 | 227.85M |
| October 01, 2026 | 229.12M |
| September 30, 2026 | 245.67M |
| September 29, 2026 | 239.94M |
| September 28, 2026 | 258.40M |
| September 25, 2026 | 238.03M |
| September 24, 2026 | 241.85M |
| September 23, 2026 | 241.85M |
| September 22, 2026 | 262.22M |
| September 21, 2026 | 262.22M |
| September 18, 2026 | 263.49M |
| September 17, 2026 | 262.86M |
| September 16, 2026 | 259.67M |
| September 15, 2026 | 257.13M |
| September 14, 2026 | 267.31M |
| September 11, 2026 | 254.58M |
| September 10, 2026 | 252.67M |
| September 09, 2026 | 261.58M |
| September 08, 2026 | 274.95M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| ACADIA Pharmaceuticals, Inc. | 3.163B |
| Alnylam Pharmaceuticals, Inc. | 20.96B |
| Anika Therapeutics, Inc. | 172.65M |
| Savara, Inc. | 919.77M |
| Arrowhead Pharmaceuticals, Inc. | 6.070B |
Market Cap Related Metrics
| PS Ratio | 1.142 |
| Price to Book Value | 5.181 |
| Price | 2.04 |
| Earnings Yield | -40.84% |